General MedicationsORALGeneric

AMPHETAMINE SULFATE

Standard Dose

5MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview AMPHETAMINE SULFATE is listed in Drugs@FDA under application 214574 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPHETAMINE SULFATE Form and strength TABLET;ORAL - 5MG Sponsor SUN PHARM INDS INC Submission history Latest submission status date: 2025-09-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMPHETAMINE SULFATE is listed in Drugs@FDA under application 214574 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMPHETAMINE SULFATE Form and strength TABLET;ORAL - 5MG Sponsor SUN PHARM INDS INC Submission history Latest submission status date: 2025-09-26 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.